SS Innovations International Launches the 2nd Global Robotic Surgery Conference, SMRSC 2025
SS Innovations International (OTC: SSII) announced its 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025) to be held in Gurugram, India, from March 7-9, 2025. The conference will showcase the company's SSi Mantra 3 Robotic Surgical System, which has already facilitated over 3,200 surgeries across 70+ hospitals globally.
The event will feature live robotic surgeries in multiple specialties and the launch of the SSi Mantra Mobile Unit, a surgical bus designed to expand access to robotic surgical care in underserved areas. The SSi Mantra 3 is notably the only robotic system worldwide with regulatory approval for telesurgery and tele-proctoring from CDSCO, enabling remote surgeries and medical education.
The system features 3-5 robotic arms, 3D 4K monitoring, and over 40 different types of robotic endo-surgical instruments. The company anticipates receiving FDA and CE Mark approvals in the second half of 2025.
SS Innovations International (OTC: SSII) ha annunciato la sua 2ª Conferenza Globale di Chirurgia Robotica Multi-Specialistica (SMRSC 2025) che si terrà a Gurugram, India, dal 7 al 9 marzo 2025. La conferenza presenterà il sistema chirurgico robotico SSi Mantra 3, che ha già facilitato oltre 3.200 interventi chirurgici in più di 70 ospedali in tutto il mondo.
L'evento includerà interventi chirurgici robotici dal vivo in diverse specialità e il lancio dell'Unità Mobile SSi Mantra, un autobus chirurgico progettato per ampliare l'accesso alle cure chirurgiche robotiche in aree svantaggiate. Il SSi Mantra 3 è notevolmente l'unico sistema robotico al mondo con approvazione normativa per la telesurgery e il tele-proctoring da parte del CDSCO, consentendo interventi chirurgici remoti e educazione medica.
Il sistema è dotato di 3-5 bracci robotici, monitoraggio 3D 4K e oltre 40 diversi tipi di strumenti endo-chirurgici robotici. L'azienda prevede di ricevere le approvazioni FDA e CE Mark nella seconda metà del 2025.
SS Innovations International (OTC: SSII) anunció su 2ª Conferencia Global de Cirugía Robótica Multi-Especialidad (SMRSC 2025) que se llevará a cabo en Gurugram, India, del 7 al 9 de marzo de 2025. La conferencia mostrará el sistema quirúrgico robótico SSi Mantra 3, que ya ha facilitado más de 3,200 cirugías en más de 70 hospitales a nivel mundial.
El evento contará con cirugías robóticas en vivo en múltiples especialidades y el lanzamiento de la Unidad Móvil SSi Mantra, un autobús quirúrgico diseñado para ampliar el acceso a la atención quirúrgica robótica en áreas desatendidas. El SSi Mantra 3 es notablemente el único sistema robótico en el mundo con aprobación regulatoria para telesurgery y tele-proctoring por parte del CDSCO, lo que permite cirugías remotas y educación médica.
El sistema cuenta con 3-5 brazos robóticos, monitoreo 3D 4K y más de 40 tipos diferentes de instrumentos endoquirúrgicos robóticos. La empresa anticipa recibir las aprobaciones de la FDA y el marcado CE en la segunda mitad de 2025.
SS Innovations International (OTC: SSII)는 2025년 3월 7일부터 9일까지 인도 구르가온에서 열리는 제2회 글로벌 다전문 로봇 수술 컨퍼런스(SMRSC 2025)를 발표했습니다. 이 컨퍼런스에서는 이미 70개 이상의 병원에서 3,200건 이상의 수술을 지원한 SSi Mantra 3 로봇 수술 시스템을 선보일 예정입니다.
이 행사에서는 여러 전문 분야에서의 실시간 로봇 수술과 SSi Mantra 모바일 유닛의 출시가 있을 예정입니다. 이 수술 버스는 저소득 지역에서 로봇 수술 치료에 대한 접근성을 확대하기 위해 설계되었습니다. SSi Mantra 3는 CDSCO로부터 원격 수술 및 원격 교육에 대한 규제 승인을 받은 유일한 로봇 시스템으로, 원격 수술 및 의학 교육이 가능합니다.
이 시스템은 3-5개의 로봇 팔, 3D 4K 모니터링 및 40종 이상의 다양한 로봇 내시경 수술 도구를 갖추고 있습니다. 회사는 2025년 하반기에 FDA 및 CE 마크 승인을 받을 것으로 예상하고 있습니다.
SS Innovations International (OTC: SSII) a annoncé sa 2ème Conférence Mondiale de Chirurgie Robotique Multi-Spécialités (SMRSC 2025) qui se tiendra à Gurugram, en Inde, du 7 au 9 mars 2025. La conférence mettra en avant le système chirurgical robotique SSi Mantra 3, qui a déjà facilité plus de 3 200 interventions chirurgicales dans plus de 70 hôpitaux à travers le monde.
L'événement présentera des opérations robotiques en direct dans plusieurs spécialités et le lancement de l'Unité Mobile SSi Mantra, un bus chirurgical conçu pour élargir l'accès aux soins chirurgicaux robotiques dans les zones défavorisées. Le SSi Mantra 3 est notamment le seul système robotique au monde à avoir obtenu l'approbation réglementaire pour la télésurgery et le télé-proctoring de la part du CDSCO, permettant ainsi des interventions à distance et une formation médicale.
Le système est équipé de 3 à 5 bras robotiques, d'une surveillance 3D 4K et de plus de 40 types différents d'instruments endo-chirurgicaux robotiques. L'entreprise prévoit de recevoir les approbations de la FDA et du marquage CE dans la seconde moitié de 2025.
SS Innovations International (OTC: SSII) hat die 2. Globale Konferenz für multi-spezialistische Robotikchirurgie (SMRSC 2025) angekündigt, die vom 7. bis 9. März 2025 in Gurugram, Indien, stattfinden wird. Die Konferenz wird das SSi Mantra 3 Robotische Chirurgiesystem präsentieren, das bereits über 3.200 Operationen in mehr als 70 Krankenhäusern weltweit ermöglicht hat.
Die Veranstaltung wird Live-Roboteroperationen in verschiedenen Fachbereichen und die Einführung der SSi Mantra Mobilen Einheit umfassen, einem chirurgischen Bus, der entwickelt wurde, um den Zugang zu robotergestützten chirurgischen Behandlungen in unterversorgten Gebieten zu erweitern. Das SSi Mantra 3 ist bemerkenswerterweise das einzige robotische System weltweit, das von der CDSCO für Telesurgery und Tele-Proctoring zugelassen ist, was Fernoperationen und medizinische Ausbildung ermöglicht.
Das System verfügt über 3-5 Roboterarme, 3D 4K-Überwachung und über 40 verschiedene Arten von robotergestützten endochirurgischen Instrumenten. Das Unternehmen rechnet damit, in der zweiten Hälfte des Jahres 2025 die FDA- und CE-Zulassungen zu erhalten.
- System already deployed in 70+ hospitals with 3,200+ surgeries performed
- Only robotic system worldwide with telesurgery regulatory approval
- FDA and CE Mark approvals expected in H2 2025
- Expanding accessibility through mobile surgical unit initiative
- Still pending important FDA and CE Mark approvals
- to regulatory approval only in India currently
FORT LAUDERDALE, Fla., March 07, 2025 (GLOBE NEWSWIRE) -- SS Innovations International, Inc. (OTC: SSII) (“SS Innovations” or the “Company”), a developer of innovative surgical robotic technologies dedicated to making world-class robotic surgery affordable for and accessible to a global population, announced the launch of its 2nd Global Multi-Specialty Robotic Surgery Conference (SMRSC 2025), organized in collaboration with leading medical societies from both national and international platforms, to be held in Gurugram, Delhi National Capital Region (NCR), India, from March 7th to 9th , 2025.
Physicians and other participants attending from all parts of the world, will have the opportunity to explore the latest advancements in robotic surgery, with a special focus on the Company’s SSi Mantra 3 Robotic Surgical System. The cutting-edge technology employed by the SSi Mantra 3, is transforming surgical robotics, offering unmatched precision and accessibility, and to date, has facilitated the performance of over 3,200 multi-specialty surgeries globally across 70+ hospitals.
The conference will feature live robotic surgeries in the General Surgery, Gynecology, Urology, Thoracic, and Cardiac Surgery fields, performed by distinguished faculty who will showcase the versatility of the SSi Mantra 3 in real-world settings. Renowned national and international experts will deliver insightful presentations, sharing their experiences and best practices with the SSi Mantra Surgical Robotic System.
Attendees will also have the opportunity to explore groundbreaking innovations, including tele-surgery, tele-proctoring, and the SSI Maya division, which is designed to leverage virtual and mixed reality to enhance surgical planning and education. With Gurugram’s pleasant weather and rich cultural offerings, the conference promises a valuable blend of learning, collaboration, and innovation in robotic surgery.
SSII will also be announcing the groundbreaking launch of its SSi Mantra Mobile Unit, a state-of-the-art mobile surgical bus, designed to expand access to advanced robotic surgical care with cutting-edge surgical capabilities, in areas that currently have little or no access to such potentially life-saving procedures.
The SSi Mantra 3 Surgical Robotic System is the only robotic system in the world to have received regulatory approval for telesurgery and tele-proctoring. Approved by the Central Drugs Standard Control Organization (CDSCO), this validation opens the door to remote surgeries and medical education, enabling healthcare professionals to collaborate across great distances. It highlights the transformative potential of technology in enhancing the accessibility and precision of healthcare, revolutionizing how surgeries are performed on a global scale. By offering the potential to bring world-class medical expertise to even the most remote corners of the globe, it sets a precedent for the future of remote healthcare, reshaping patient care.
More information and a list of some of the many world-renowned participants, which include Dr. Frederic Moll, Indian Cabinet Ministers, Dr. Michio Kaku, among many others at this event is available at https://ssinnovations.com/SMRSC-2025/.
About SS Innovations:
SS Innovations International, Inc. (OTC: SSII) is a developer of innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger part of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system, and “SSi Mudra” its wide range of surgical instruments capable of supporting a variety of surgical procedures including robotic cardiac surgery. SS Innovations’ business operations are headquartered in India and the Company plans to expand the presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions, globally. For more information, visit our website at ssinnovations.com or LinkedIn for updates.
About the SSi Mantra:
The SSi Mantra Surgical Robotic System, by SS Innovations, is a modular multi-arm system with many advanced technology features. It allows for the use of 3-5 robotic arms, has an open-faced ergonomic Surgeon Command Centre, 32-inch large 3D 4K monitor, a 23-inch 2D Touch panel monitor for all patient related information display, a virtual real-time image of the robotic Patient Side Arm Carts, and the ability for superimposition of 3D models of diagnostic imaging. The Vision Cart gives the table-side team the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The modular robotic arms give flexibility in positioning and the number of arms to be used. This allows for collision-free conduct of surgical operations. There are over 40 different types of robotic endo-surgical instruments that can be used for different specialties including cardiac surgery. The learning curve for surgeons is shorter due to the SSi Mantra’s ergonomic design and user-friendly features.
The SSi Mantra has been clinically validated in India in more than 80 different types of surgical procedures. SS Innovations has commenced the regulatory approval process in the United States and the European Union and anticipates receiving FDA approval to market and CE Mark approval in the second half of 2025.
Forward-Looking Statements:
This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations International’s future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.
Follow us on:
LinkedIn: https://www.linkedin.com/company/ssinnovationsgroup/
YouTube: https://www.youtube.com/@ssinnovations
For media inquiries, please contact:
+1-212-739-0300
FAQ
How many surgeries has the SSi Mantra 3 Robotic System performed globally?
When is SSII expected to receive FDA and CE Mark approvals?
What unique regulatory approval does SSII's SSi Mantra 3 have?
What new initiative is SSII launching at SMRSC 2025?
How many types of surgical instruments can the SSi Mantra system use?
